The current status of heart failure diagnostic biomarkers
Heart failure (HF) affects approximately 23 million individuals worldwide and this number is
increasing, due to an aging and growing population. Early detection of HF is crucial in the …
increasing, due to an aging and growing population. Early detection of HF is crucial in the …
Assessment of lipid peroxidation and artificial neural network models in early Alzheimer Disease diagnosis
C Peña-Bautista, T Durand, C Oger, M Baquero… - Clinical …, 2019 - Elsevier
Objective: Lipid peroxidation constitutes a molecular mechanism involved in early Alzheimer
Disease (AD) stages, and artificial neural network (ANN) analysis is a promising non-linear …
Disease (AD) stages, and artificial neural network (ANN) analysis is a promising non-linear …
Bad players in AL amyloidosis in the current era of treatment
N Kreiniz, MA Gertz - Expert review of hematology, 2023 - Taylor & Francis
ABSTRACT Introduction Systemic AL amyloidosis (ALA) is a clonal plasma cell (PC) disease
characterized by deposition of amyloid fibrils in different organs and tissues. Traditionally …
characterized by deposition of amyloid fibrils in different organs and tissues. Traditionally …
Urinary N-terminal pro–B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study
K Yamasaki, J Hata, T Ide, T Nagata, S Sakata… - … health and preventive …, 2021 - Springer
Background Epidemiological evidence has shown that serum N-terminal pro-brain
natriuretic peptide (NT-proBNP) concentrations, a diagnostic biomarker for heart failure, are …
natriuretic peptide (NT-proBNP) concentrations, a diagnostic biomarker for heart failure, are …
Expression of pericardial fluid T‑cells and related inflammatory cytokines in patients with chronic heart failure
R Iskandar, S Liu, F Xiang, W Chen… - Experimental and …, 2017 - spandidos-publications.com
Pericardial fluid, as a biochemical indicator of heart status, directly indicates pathological
alteration to the heart. The accumulation of pericardial fluid can be attributed to an …
alteration to the heart. The accumulation of pericardial fluid can be attributed to an …
NT-proBNP в слюне и сыворотке крови в норме и при пародонтите
ДЮ Соснин, ОС Гилева, ЛА Мозговая… - Клиническая …, 2018 - cyberleninka.ru
Изучена концентрация NT-proBNP в слюне и сыворотке крови. В исследование
включены 58 человек, разделённых на две группы. Основную (1-ю) группу составили 34 …
включены 58 человек, разделённых на две группы. Основную (1-ю) группу составили 34 …
Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain
S Reynen, M Schlossbauer, U Hubauer… - ESC Heart …, 2021 - Wiley Online Library
Aims The objective of this study was to investigate the prognostic value of urinary N‐terminal
pro‐brain natriuretic peptide (NT‐proBNP) compared with plasma NT‐proBNP in patients …
pro‐brain natriuretic peptide (NT‐proBNP) compared with plasma NT‐proBNP in patients …
重组人脑利钠肽治疗高龄心衰患者的疗效及安全性
王聿杰， 黄带发， 张晓琳， 车海龙 - 实用临床医药杂志, 2015 - jcmp.yzu.edu.cn
目的评价重组人脑利钠肽(rhBNP) 治疗高龄心衰患者的疗效及安全性. 方法108 例年龄≥ 80
岁的高龄心衰患者随机分为试验组(rhBNP 治疗) 和对照组(硝酸甘油治疗), 每组54 例. 观察2 …
岁的高龄心衰患者随机分为试验组(rhBNP 治疗) 和对照组(硝酸甘油治疗), 每组54 例. 观察2 …
Urine N‐terminal pro b‐type natriuretic peptide is predictive of heart failure‐related emergency department visits
Aims Emergency department (ED) visits for decompensated heart failure (HF) are frequent
and associated with poor long‐term outcomes in patients with HF. Serum N‐terminal pro b …
and associated with poor long‐term outcomes in patients with HF. Serum N‐terminal pro b …
[PDF][PDF] 加倍剂量缬沙坦治疗老年高血压合并微量蛋白尿的临床疗效观察
金俊， 张臻， 崔亮， 赵喆， 谈世进 - 实用老年医学, 2015 - sylnyx.com
目的探讨加倍剂量缬沙坦治疗老年高血压患者合并微量蛋白尿的疗效和安全性.
方法选择老年高血压合并微量蛋白尿患者89 例, 单药治疗血压均未达标, 随机分为对照组48 …
方法选择老年高血压合并微量蛋白尿患者89 例, 单药治疗血压均未达标, 随机分为对照组48 …